Lars Søndergaard

Lars Søndergaard's AcademicInfluence.com Rankings

Lars Søndergaard

Philosophy

#9088

World Rank

#12593

Historical Rank

Logic

#6082

World Rank

#7564

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Lars Søndergaard's Degrees

Doctorate Medicine University of Copenhagen
PhD Cardiovascular Surgery University of Copenhagen

Why Is Lars Søndergaard Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Lars Søndergaard's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients (2017) (1992)
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. (2015) (756)
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke (2017) (724)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. (2015) (711)
Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study (2017) (636)
2020 ESC Guidelines for the management of adult congenital heart disease. (2020) (560)
Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial (2006) (348)
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ (2017) (321)
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. (2017) (315)
Transcatheter aortic valve replacement in bicuspid aortic valve disease. (2014) (280)
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials. (2016) (272)
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. (2019) (272)
Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk. (2019) (238)
Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. (2019) (224)
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death. (2016) (221)
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. (2013) (213)
Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study. (2014) (209)
Management of Conduction Disturbances Associated With Transcatheter Aortic Valve Replacement: JACC Scientific Expert Panel. (2019) (185)
Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. (2010) (175)
Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis. (2016) (172)
The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement? (2015) (168)
Bosentan Improves Exercise Capacity in Adolescents and Adults After Fontan Operation: The TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption) Study (2014) (168)
Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial (2016) (158)
Percutaneous Transcatheter Mitral Valve Replacement: An Overview of Devices in Preclinical and Early Clinical Evaluation (2014) (152)
Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves (2017) (149)
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. (2019) (146)
Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement. (2017) (138)
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Societ (2017) (134)
Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical Risk (2019) (129)
Transcatheter aortic valve implantation: current status and future perspectives. (2015) (127)
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures. (2017) (120)
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR): Impact on Final Valve Orientation and Coronary Artery Overlap. (2020) (110)
Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. (2002) (110)
Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis. (2020) (110)
Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients. (2019) (103)
Transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel interatrial implant to lower left atrial pressure (2014) (100)
Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study (2017) (98)
Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE) (2021) (97)
Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction. (2020) (95)
Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart disease. (2005) (93)
Long-Term Outcome of Mustard/Senning Correction for Transposition of the Great Arteries in Sweden and Denmark (2015) (90)
Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. (2017) (88)
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement. (2020) (84)
Prosthetic Valve Endocarditis After Transcatheter Aortic Valve Implantation (2015) (83)
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach. (2016) (80)
Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI) (2018) (80)
Endocarditis After Transcatheter Pulmonary Valve Replacement. (2018) (79)
Treatment with oral beta‐blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction (2014) (78)
Live-Born Major Congenital Heart Disease in Denmark: Incidence, Detection Rate, and Termination of Pregnancy Rate From 1996 to 2013 (2018) (77)
Bicuspid Aortic Valve Anatomy and Relationship With Devices: The BAVARD Multicenter Registry A European Picture of Contemporary Multidetector Computed Tomography Sizing for Bicuspid Valves (2019) (77)
Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves. (2020) (76)
First-in-Human Case of Transfemoral CardiAQ Mitral Valve Implantation (2015) (76)
Short- and long-term changes in myocardial function, morphology, edema, and infarct mass after ST-segment elevation myocardial infarction evaluated by serial magnetic resonance imaging. (2007) (75)
[Pregnancy and heart disease]. (2003) (74)
Evaluation of current practices in transcatheter aortic valve implantation: The WRITTEN (WoRldwIde TAVI ExperieNce) survey. (2017) (74)
Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration). (2019) (74)
Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement (2021) (73)
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated Stroke. (2020) (71)
Long-Term Risk of Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2019) (71)
Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and its Impact on Valvular Function and Coronary Filling. (2018) (71)
Incidence of infective endocarditis among patients considered at high risk (2018) (71)
Left ventricular remodeling in the first year after acute myocardial infarction and the predictive value of N-terminal pro brain natriuretic peptide. (2002) (67)
Mortality and Heart Failure Hospitalization in Patients With Conduction Abnormalities After Transcatheter Aortic Valve Replacement. (2019) (65)
Retinal oxygen saturation in patients with systemic hypoxemia. (2011) (64)
Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) presenting with ventricular fibrillation in an adult: a case report (2008) (63)
Past and current cause-specific mortality in Eisenmenger syndrome (2017) (63)
Patient-Specific Computer Simulation to Elucidate the Role of Contact Pressure in the Development of New Conduction Abnormalities After Catheter-Based Implantation of a Self-Expanding Aortic Valve (2018) (62)
Transcatheter mitral valve implantation via transapical approach: an early experience. (2015) (60)
Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update (2014) (59)
One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. (2018) (57)
Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease (2015) (56)
Quality of life and cognitive function in Fontan patients, a population-based study. (2013) (56)
Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis. (2019) (55)
2020 ESC Guidelines for the management of adult congenital heart disease (2021) (54)
Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis (2020) (52)
Echocardiographic and clinical outcomes of central versus noncentral percutaneous edge-to-edge repair of degenerative mitral regurgitation. (2013) (52)
A comparative study of different imaging modalities for successful percutaneous left atrial appendage closure (2017) (51)
Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy? (2019) (50)
No clinical effect of prosthesis-patient mismatch after transcatheter versus surgical aortic valve replacement in intermediate- and low-risk patients with severe aortic valve stenosis at mid-term follow-up: an analysis from the NOTION trial. (2016) (49)
Subclinical leaflet thickening and stent frame geometry in self-expanding transcatheter heart valves. (2017) (49)
Immediate Post-Procedural 12-Lead Electrocardiography as Predictor of Late Conduction Defects After Transcatheter Aortic Valve Replacement. (2018) (47)
Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN. (2019) (47)
Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves. (2021) (46)
Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. (2013) (46)
The Nordic Aortic Valve Intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial (2013) (45)
Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis. (2017) (43)
Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease. (2013) (42)
The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease. (2013) (42)
Percutaneous pulmonary valve implantation preceded by routine prestenting with a bare metal stent (2011) (42)
Univentricular hearts in Denmark 1977 to 2009: incidence and survival. (2013) (41)
Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family. (2017) (40)
Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement. (2017) (40)
Vitamin K Antagonists versus Direct Oral Anticoagulants After Transcatheter Aortic Valve Implantation in Atrial Fibrillation. (2019) (40)
Transcatheter heart valve interventions: where are we? Where are we going? (2019) (40)
Anticoagulation in adults with congenital heart disease: The who, the when and the how? (2014) (40)
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis (2020) (39)
Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation. (2015) (38)
Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses. (2021) (38)
Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ mitral valve bioprosthesis: first procedure description and 30-day follow-up. (2016) (38)
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography. (2020) (38)
Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. (2019) (37)
Thromboembolic Complications in Fontan Patients: Population-Based Prevalence and Exploration of the Etiology (2013) (37)
Patient-Reported Outcomes in Adult Survivors with Single-Ventricle Physiology (2011) (36)
Transcatheter valve-in-valve implantation due to severe aortic regurgitation in a degenerated aortic homograft. (2009) (35)
New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review. (2015) (35)
Patient-Specific Computer Simulation of Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Morphology. (2019) (34)
Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registry. (2016) (34)
Self-Expanding Transcatheter Aortic Valve System for Symptomatic High-Risk Patients With Severe Aortic Stenosis. (2017) (33)
Screening of adults with congenital cardiac disease lost for follow-up (2007) (33)
Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation. (2014) (32)
Choice of Treatment for Aortic Valve Stenosis in the Era of Transcatheter Aortic Valve Replacement in Eastern Denmark (2005 to 2015). (2016) (32)
Frequency and Effect of Access-Related Vascular Injury and Subsequent Vascular Intervention After Transcatheter Aortic Valve Replacement. (2016) (32)
Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement (2020) (31)
Effect of gender on results of percutaneous edge-to-edge mitral valve repair with MitraClip system. (2015) (30)
Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation. (2018) (29)
Incidence of infective endocarditis in patients considered at moderate risk (2018) (29)
Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure. (2015) (29)
Clinical outcome of transcatheter treatment of heart failure with preserved or mildly reduced ejection fraction using a novel implant. (2015) (28)
How do we define congenital heart defects for scientific studies? (2012) (28)
Infective endocarditis in right ventricular outflow tract conduits: a register-based comparison of homografts, Contegra grafts and Melody transcatheter valves. (2019) (28)
Arrhythmia and exercise intolerance in Fontan patients: current status and future burden. (2013) (28)
Effects of eHealth physical activity encouragement in adolescents with complex congenital heart disease: The PReVaiL randomized clinical trial. (2016) (28)
The CardiAQ transcatheter mitral valve implantation system. (2015) (27)
Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial). (2019) (27)
Acute Fatal Pulmonary Vein Occlusion after Catheter Ablation of Atrial Fibrillation (2004) (26)
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions. (2021) (25)
Bicuspid aortic valve sizing for transcatheter aortic valve implantation: Development and validation of an algorithm based on multi-slice computed tomography. (2020) (25)
Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Prosthesis: The PORTICO-I Trial 1-Year Outcomes. (2018) (25)
Validation of a computational model aiming to optimize preprocedural planning in percutaneous left atrial appendage closure. (2020) (25)
Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study (2018) (24)
Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977–2012 (2017) (24)
Cyanotic congenital heart disease and atherosclerosis (2017) (23)
2020 ESC Guidelines for themanagement of adult congenital heart disease (2021) (23)
The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes (2021) (23)
Cancer risk among patients with congenital heart defects: a nationwide follow-up study (2013) (21)
Transcatheter aortic valve implantation: don't forget the coronary arteries! (2018) (21)
Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease (2018) (20)
Nationwide Study of Sudden Cardiac Death in People With Congenital Heart Defects Aged 0 to 35 Years (2018) (20)
The effect of Bosentan on exercise capacity in Fontan patients; rationale and design for the TEMPO study (2013) (20)
Differences in left ventricular remodelling in patients with aortic stenosis treated with transcatheter aortic valve replacement with corevalve prostheses compared to surgery with porcine or bovine biological prostheses (2018) (20)
Multicenter Study of Endocarditis After Transcatheter Pulmonary Valve Replacement. (2021) (20)
Five-year results from a prospective multicentre study of percutaneous pulmonary valve implantation demonstrate sustained removal of significant pulmonary regurgitation, improved right ventricular outflow tract obstruction and improved quality of life. (2017) (20)
Hemodynamic causes of exercise intolerance in Fontan patients. (2014) (20)
Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves. (2020) (19)
Copenhagen Baby Heart Study: a population study of newborns with prenatal inclusion (2018) (19)
Simplification and optimization of transcatheter aortic valve implantation – fast-track course without compromising safety and efficacy (2018) (19)
Effect of advanced chronic kidney disease in clinical and echocardiographic outcomes of patients treated with MitraClip system. (2015) (19)
Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation (2019) (19)
Design and rationale for the PREVAIL study: effect of e-Health individually tailored encouragements to physical exercise on aerobic fitness among adolescents with congenital heart disease--a randomized clinical trial. (2012) (19)
Measures of right ventricular function after transcatheter versus surgical aortic valve replacement. (2016) (19)
Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: Results from a prospective European multicenter study (2017) (18)
Subclinical atherosclerosis in patients with cyanotic congenital heart disease. (2019) (18)
Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR: A Multicenter Registry. (2020) (18)
ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement. (2021) (18)
Device-Related Thrombus After Left Atrial Appendage Closure (2021) (18)
Neurohumoral prediction of left‐ventricular morphologic response to β‐blockade with metoprolol in chronic left‐ventricular systolic heart failure (2002) (18)
The first clinical experience with the new GORE® septal occluder (GSO). (2013) (18)
Value of FEops HEARTguide patient-specific computational simulations in the planning of left atrial appendage closure with the Amplatzer Amulet closure device: rationale and design of the PREDICT-LAA study (2020) (17)
Effects of Chronic Severe Pulmonary Regurgitation and Percutaneous Valve Repair on Right Ventricular Geometry and Contractility Assessed by Tissue Doppler Echocardiography (2010) (17)
Coronary artery disease, revascularization, and clinical outcomes in transcatheter aortic valve replacement: Real‐world results from the East Denmark Heart Registry (2018) (17)
Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far (2019) (17)
Patient-Specific Computer Simulation in TAVR With the Self-Expanding Evolut R Valve. (2020) (17)
Outcome after heart–lung or lung transplantation in patients with Eisenmenger syndrome (2019) (16)
Patient selection for transcatheter mitral valve implantation: why is it so hard to find patients? (2018) (16)
Effect of Transcatheter Aortic Valve Replacement on Concomitant Mitral Regurgitation and Its Impact on Mortality. (2021) (16)
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement. (2022) (16)
PFO closuRE and CryptogenIc StrokE (PRECISE) registry: a multi-center, international registry (2012) (16)
Use of 3-Dimensional Models to Optimize Pre-Procedural Planning of Percutaneous Left Atrial Appendage Closure. (2017) (16)
One-Year Outcomes with a Self-Expanding, Repositionable Transcatheter Heart Valve in Severe Aortic Stenosis Patients: PORTICO-I (2018) (16)
Heart Team therapeutic decision-making and treatment in severe aortic valve stenosis (2016) (15)
Recovery from Anemia in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation – Prevalence, Predictors and Clinical Outcome (2014) (15)
Short- and Long-Term Mortality and Stroke Risk After Transcatheter Aortic Valve Implantation. (2018) (15)
Transcatheter Aortic Valve Replacement: Role of Multimodality Imaging in Common and Complex Clinical Scenarios. (2019) (15)
The evolution of device technology in transcatheter aortic valve implantation. (2019) (15)
Cor triatriatum sinistrum diagnosed in the adulthood: a systematic review (2019) (15)
Cardiac surgery in grown-up congenital heart patients. Will the surgical workload increase? (2008) (15)
Time to Explore Transcatheter Aortic Valve Replacement in Younger, Low-Risk Patients. (2016) (15)
Reintervention and Survival After Transcatheter Pulmonary Valve Replacement (2022) (15)
ESC Working Group Position Paper: Transcatheter adult congenital heart disease interventions: organization of care – recommendations from a Joint Working Group of the European Society of Cardiology (ESC), European Association of Pediatric and Congenital Cardiology (AEPC), and the European Associatio (2018) (14)
New insights into the aspects of pulmonary diffusing capacity in Fontan patients (2013) (14)
Cost-Effectiveness of Transcatheter versus Surgical Aortic Valve Replacement inPatients at Lower Surgical Risk: Results from the NOTION Trial. (2019) (14)
Isolated pulmonary regurgitation causes decreased right ventricular longitudinal function and compensatory increased septal pumping in a porcine model (2017) (14)
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE neo valve (2020) (14)
Leaflet Thrombosis after TAVI. (2017) (13)
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation. (2020) (13)
Technical Considerations for Transcatheter Aortic Valve Replacement With ACURATE neo2. (2020) (13)
Transcatheter aortic valve implantation with the ACURATE Neo valve: indications, procedural aspects and clinical outcomes. (2020) (13)
An overview of current and emerging devices for percutaneous left atrial appendage closure. (2019) (13)
Rapid adoption of transcatheter aortic valve replacement in intermediate- and high-risk patients to treat severe aortic valve stenosis. (2017) (12)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. (2016) (12)
Thirty-day Clinical Outcomes of the Evolut PRO Self-Expanding Transcatheter Aortic Valve: The International FORWARD PRO Study. (2020) (12)
Transcatheter Aortic Valve Replacement Using the Portico System: 10 Things to Remember. (2016) (12)
Impacts of acute severe pulmonary regurgitation on right ventricular geometry and contractility assessed by tissue-Doppler echocardiography. (2010) (12)
Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis undergoing trans-catheter valve replacement with new generation devices: Insight from the BEAT international collaborative registry. (2020) (12)
1-Year Outcomes of the CENTERA-EU Trial Assessing a Novel Self-Expanding Transcatheter Heart Valve. (2019) (12)
Mortality and morbidity of major congenital heart disease related to general prenatal screening for malformations. (2019) (12)
The accuracy of prenatal diagnosis of major congenital heart disease is increasing (2020) (12)
Intravascular iliac artery lithotripsy to enable transfemoral thoracic endovascular aortic repair (2020) (12)
Antithrombotic Management After Transcatheter Aortic Valve Replacement: More Questions Than Answers. (2017) (12)
Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective (2019) (12)
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke. (2021) (11)
A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention (2020) (11)
Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study. (2018) (11)
Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neoskirt Height and Leaflet Overhang. (2022) (11)
Transcatheter mitral valve repair: an overview of current and future devices (2021) (11)
Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study (2017) (11)
Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1‐year results from the CHOICE‐MI registry (2022) (11)
Long-term follow-up after stent graft placement for access-site and access-related vascular injury during TAVI - The Bonn-Copenhagen experience. (2019) (11)
Peripheral intravascular lithotripsy of iliofemoral arteries to facilitate transfemoral TAVI: a multicentre prospective registry. (2021) (10)
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. (2020) (10)
Will PARTNER change my practice? Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A trial - transcatheter or surgical aortic-valve replacement in intermediate-risk patients. (2016) (10)
Challenges When Expanding Transcatheter Aortic Valve Implantation to Younger Patients (2018) (10)
A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane. (2020) (10)
Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation. (2022) (10)
Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Review. (2022) (10)
Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective (2018) (10)
Myocardial hypertrophy after pulmonary regurgitation and valve implantation in pigs. (2012) (10)
Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2020) (9)
Cusp Symmetry and Coronary Ostial Eccentricity and its Impact on Coronary Access Following TAVR (2022) (9)
Percutaneous pulmonary valve replacement after different duration of free pulmonary regurgitation in a porcine model: effects on the right ventricle. (2013) (9)
Permanent Pacemaker Implantation Following Valve-in-Valve Transcatheter Aortic Valve Replacement: VIVID Registry. (2021) (9)
Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry (2020) (9)
Infective endocarditis in patients who have undergone transcatheter aortic valve implantation: a review. (2020) (9)
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2021) (9)
The year in cardiology 2017: valvular heart disease. (2018) (9)
Images in cardiovascular medicine. Pulmonary artery thrombosis and hemoptysis in Eisenmenger syndrome. (2007) (9)
Early and late risk of ischemic stroke after TAVR as compared to a nationwide background population (2019) (9)
When operable patients become inoperable: conversion of a surgical aortic valve replacement into transcatheter aortic valve implantation. (2009) (8)
TCT-107 Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes from the SURTAVI Trial (2017) (8)
Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2021) (8)
Direct Current Cardioversion of Atrial Fibrillation in Patients With Left Atrial Appendage Occlusion Devices. (2019) (8)
Structural abnormalities after aortic root replacement with stentless xenograft. (2021) (8)
Severe Valvular Heart Disease and COVID-19: Results from the Multicenter International Valve Disease Registry (2021) (8)
Survival and cause of death after transcatheter aortic valve replacement as compared to an age- and sex-matched background population. (2017) (8)
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial. (2022) (8)
Computed tomography-based oversizing and incidence of paravalvular aortic regurgitation and permanent pacemaker implantation with a new-generation self-expanding transcatheter heart valve. (2018) (8)
Standardized distances for placement of REBOA in patients with aortic stenosis (2020) (8)
Repeat transcatheter aortic valve replacement and implications for transcatheter heart valve performance: insights from bench testing. (2021) (8)
Health-related fitness profiles in adolescents with complex congenital heart disease. (2015) (8)
The “Chimney approach” for transcatheter aortic valve implantation: A strategy for trans axillarian bareback approach in patients with no other access options (2015) (7)
[POL-PAVTI--Polish report on transcatheter pulmonary artery valve implantation of Melody-Medtronic prosthesis in the first 14 patients in Poland]. (2009) (7)
Promising results after percutaneous mitral valve repair. (2011) (7)
Horizontal Aorta in Transcatheter Self-Expanding Valves (2021) (7)
Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve. (2020) (7)
Intracardiac echocardiography unveils large thrombus on a restenotic TAVR prosthesis more than 6 years after implantation. (2016) (7)
Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization (2022) (7)
Durability of transcatheter bioprosthetic aortic valves: the story so far. (2019) (7)
Transcatheter Aortic Valve Replacement with the Latest-Iteration Self-Expanding or Balloon-Expandable Valves: The Multicenter OPERA-TAVI Registry. (2022) (7)
Long-Term Changes in Invasive Physiological Pressure Indices of Stenosis Severity Following Transcatheter Aortic Valve Implantation. (2021) (7)
Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program (2020) (6)
Clinical valve thrombosis and subclinical leaflet thrombosis in transcatheter aortic heart valves: clinical manifestations, diagnosis, and treatment (2018) (6)
Intravascular Lithotripsy-Assisted Transfemoral TAVI: The Copenhagen Experience and Literature Review (2021) (6)
Neonatal Risk in Children of Women With Congenital Heart Disease: A Cohort Study With Focus on Socioeconomic Status (2019) (6)
Transcatheter aortic valve implantation in a patient with severe native aortic regurgitation after infective endocarditis. (2014) (6)
Performance of the TRUE dilatation balloon valvuloplasty catheter beyond rated burst pressure: A bench study (2020) (6)
30-Day and 1-Year Outcomes With HYDRA Self-Expanding Transcatheter Aortic Valve (2022) (6)
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2. (2022) (6)
Advanced Therapy in Eisenmenger Syndrome: A Systematic Review (2017) (6)
Title: Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study. (2021) (6)
Overexpansion of older generation balloon expandable transcatheter heart valves: An ex‐vivo bench study (2019) (6)
Aortic valve replacement vs. balloon-expandable and self-expandable transcatheter implantation: A network meta-analysis. (2021) (6)
Coronary Access Following Redo TAVR: Impact of THV Design, Implant Technique, and Cell Misalignment. (2022) (6)
Percutaneous Transaxillary versus Surgically-Assisted Transsubclavian TAVR: A Single Center Experience (2021) (5)
Frailty: An Important Measure in Patients Considered for Transcatheter Aortic Valve Replacement. (2018) (5)
Randomized blinded trial of automated REBOA during CPR in a porcine model of cardiac arrest. (2021) (5)
Left Atrial Appendage Closure: Prevention and Management of Periprocedural and Postprocedural Complications. (2020) (5)
Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge (2021) (5)
TCT-752 Transcatheter Aortic Valve Replacement in Europe: The 2013 Update (2013) (5)
Percutaneous closure of congenital aortocaval fistula with a coexisting secundum atrial septal defect (2011) (5)
Technical Considerations for Transcatheter Aortic Valve Replacement With the Navitor Transcatheter Heart Valve. (2021) (5)
ContributionTransc theter Aor c Valve Replacement Reevaluation of the Indications for Permanent Pacemaker Implantation After Transcatheter Aortic Valve Implantation (2014) (5)
Subclinical leaflet thrombosis - a concern, but also an issue? (2018) (4)
Left atrial appendage occlusion in chicken‐wing anatomies: Imaging assessment, procedural, and clinical outcomes of the “sandwich technique” (2021) (4)
Diagnostic Potential of Intracardiac Echocardiography in Patients with Suspected Prosthetic Valve Endocarditis. (2019) (4)
Transcatheter Mitral Valve Replacement: Current Evidence and Concepts (2021) (4)
Threshold for calcium volume evaluation in patients with aortic valve stenosis: correlation with Agatston score. (2020) (4)
Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. (2023) (4)
CRT-600.06 Clinical Outcomes and Valve Hemodynamics Following Transcatheter and Surgical Aortic Valve Replacement (2020) (4)
Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot. (2021) (4)
Patients and informal caregivers' experience of surgical and transcatheter aortic valve replacement: Real‐world data contributing to establish value‐based medicine in Denmark (2019) (4)
Clinical Impact of Atrial Fibrillation After Transcatheter Aortic Valve Replacement. (2019) (4)
Incidence, Causes, and Outcomes Associated With Urgent Implantation of a Supplementary Valve During Transcatheter Aortic Valve Replacement. (2021) (4)
Perivalvular Extension of Infective Endocarditis after Transcatheter Aortic Valve Replacement. (2021) (4)
Microcirculatory Function in Nonhypertrophic and Hypertrophic Myocardium in Patients With Aortic Valve Stenosis (2022) (4)
Subclinical hypothyroidism: A common finding in adult patients with cyanotic congenital heart disease (2018) (4)
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk. (2022) (4)
Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience. (2020) (4)
Cardiovascular complications in patients with total cavopulmonary connection: A nationwide cohort study. (2019) (4)
Original paper Transvascular pulmonary valve implantation – early results of the first Polish experience (2009) (4)
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves. (2022) (4)
Rationale, Definitions, Techniques, and Outcomes of Commissural Alignment in TAVR: From the ALIGN-TAVR Consortium. (2022) (4)
The role of device closure of patent foramen ovale in patients with cryptogenic stroke (2020) (4)
TCT-448 Transcatheter aortic valve replacement for isolated severe native aortic valve regurgitation – results from the TAVR-NAVR Registry (2017) (4)
Bioprosthetic valve fracture performed before versus after valve-in-valve intervention: Insights from bench testing. (2019) (4)
Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation (2020) (4)
Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study (2021) (4)
Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. (2017) (4)
Intravascular Lithotripsy-Assisted Transfemoral Transcatheter Aortic Valve Implantation. (2022) (4)
Recommendations on Securing Microbiological Specimens to Guide the Multidisciplinary Management of Infective Native Aortic Aneurysms. (2020) (4)
Prophylactic permanent pacemaker strategy in patients with right bundle branch block undergoing transcatheter aortic valve replacement. (2021) (4)
Impact of implant depth on hydrodynamic function with the ALLEGRA transcatheter heart valve following valve-in-valve intervention. (2020) (4)
Very early infective endocarditis after transcatheter aortic valve replacement (2022) (3)
Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry (2022) (3)
Anatomical challenges for transcatheter mitral valve intervention. (2016) (3)
Indications, current adoption and future perspectives for percutaneous left atrial appendage closure. (2019) (3)
TCT-416 Balloon vs Self-Expandable valve for the treatment of bicuspid Aortic valve sTenosis: insights from the BEAT international collaborative registry (2018) (3)
Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices. (2022) (3)
QUANTITATIVE ASSESSMENT OF ACUTE REGURGITATION FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: A MULTICENTER POOLED ANALYSIS OF 2,258 VALVES (2020) (3)
Transcatheter Aortic Valve Replacement for Degenerated Transcatheter Aortic Valves (2021) (3)
Clinical evaluation of the Hydra self‐expanding transcatheter aortic valve: 6 month results from the GENESIS trial (2021) (3)
Current status and future perspectives for transcatheter and surgical aortic valve replacement: the role of aortic valve surgery in the era of transcatheter-based therapies. (2018) (3)
State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries. (2018) (3)
Center Valve Preference and Outcomes of Transcatheter Aortic Valve Replacement: Insights From the AMTRAC Registry. (2022) (3)
Transcatheter aortic valve implantation with the self-expanding Portico valve system in an all-comers population: procedural and clinical outcomes. (2018) (3)
Tailoring the valve choice to the patient: contemporary choices and their optimal applications. (2020) (3)
Time to reconsider when to re-valve for free pulmonary regurgitation in tetralogy of Fallot? (2019) (3)
Computed Tomography-Based Selection of Transseptal Puncture Site for Percutaneous Left Atrial Appendage Closure. (2021) (3)
Cause‐Specific Mortality in Patients During Long‐Term Follow‐Up After Atrial Switch for Transposition of the Great Arteries (2022) (3)
Transcatheter aortic valve implantation in patients with longer life expectancy: what measures are needed? (2018) (3)
Annular size and interaction with trans-catheter aortic valves for treatment of severe bicuspid aortic valve stenosis: Insights from the BEAT registry. (2021) (3)
Survival after aortic root replacement with a stentless xenograft is determined by patient characteristics. (2021) (3)
An assessment of annual procedure volumes and therapy adoption of transcatheter closure of patent foramen ovale in four European countries (2020) (3)
Percutaneous management of an embolised MANTA large bore arteriotomy closure device. (2019) (3)
TAVR in bicuspid aortic valve stenosis: “We are not there yet” to draw final conclusions (2018) (3)
Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis (2021) (3)
Iatrogenic type-A aortic dissection due to transcatheter aortic valve implantation (2021) (3)
Association of Atrial Septal Aneurysm and Shunt Size With Stroke Recurrence and Benefit From Patent Foramen Ovale Closure. (2022) (3)
Meta-Analysis Comparing Valve Durability Among Different Transcatheter and Surgical Aortic Valve Bioprosthesis. (2021) (3)
Initial European experience with transcaval transcatheter aortic valve implantation. (2019) (3)
Adolescents and adults with Fontan circulation: insights from the PREpArE-Fontan registry (2021) (2)
Response letter to: "hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: facts or technical artifacts? (2013) (2)
Severe mitral annular calcification and TAVR: not an innocent bystander (2017) (2)
Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Low Surgical Risk. (2019) (2)
First-in-human results of the OMEGA™ Left Atrial Appendage Occluder for Patients with Non-Valvular Atrial Fibrillation. (2020) (2)
[Primary cardiac lymphoma]. (2001) (2)
The Antegrade-Retrograde Technique Applied in Uncrossable Valve-in-Valve TAVR: A Step-by-Step Guide. (2020) (2)
Contemporary management of severe symptomatic bicuspid aortic valve stenosis: the BiTri Registry. (2020) (2)
Infective Endocarditis Caused by Staphylococcus Aureus after Transcatheter Aortic Valve Replacement. (2021) (2)
How should I treat severe paravalvular leakage after TAVI? (2013) (2)
Percutaneous Left Atrial Appendage Closure Following Transcatheter Aortic Valve Replacement: Results from The ATTRACTIVE Study (2018) (2)
TCT-692 Multicentre clinical study evaluating a novel resheatable self-expanding transcatheter aortic valve system (2014) (2)
TCT-811 First-in-Human CardiAQ Transcatheter Mitral Valve Implantation via Transapical Approach (2014) (2)
TCT-77 Midterm results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved Ejection Fraction (2014) (2)
Sleep-disordered breathing in Eisenmenger Syndrome. (2016) (2)
Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation. (2022) (2)
Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis treated with transcatheter valve replacement: insights from the BEAT international collaborative registry (2020) (2)
Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial (2022) (2)
The role of the Heart Team in the planning of aortic valve replacement. (2019) (2)
Percutaneous Transfemoral TAVR With Direct Puncture and Successful Closure of Aortobifemoral Bypass Graft (2019) (2)
Intracardiac Echocardiographic Guidance for Left Atrial Appendage Occlusion: Is This the ChoICE for the Future? (2018) (2)
INITIAL SIX MONTHS RESULTS OF A NOVEL INTERATRIAL SHUNT THERAPY FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION (2014) (2)
TCT-136 Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction (2013) (2)
[Percutaneous aortic valve replacement - initial experience and results]. (2009) (2)
Doses to Patients in Interventional Cardiology (2009) (2)
Expanding the indications for transcatheter aortic valve implantation: is it time to treat low risk patients? (2018) (2)
Imaging risk features for device related pulmonary artery injury after left atrial appendage closure with Amplatzer™ Amulet™ device (2020) (2)
Are we too simple in planning complex structural interventions? The potential role of cardiac computed tomography to prepare for percutaneous left atrial appendage closure. (2019) (2)
Risk of Congenital Heart Defects in Offspring of Affected Mothers and Fathers (2022) (2)
Procedural outcomes of the 34 mm EvolutR Transcatheter valve in a real-world population insights from the HORSE multicenter collaborative registry. (2022) (2)
Antithrombotic therapy after TAVI: where are we going? (2019) (2)
Transcatheter adult congenital heart disease interventions: organization of care – recommendations from a Joint Working Group of the European Society of Cardiology (ESC), European Association of Pediatric and Congenital Cardiology (AEPC), and the European Association of Percutaneous Cardiac Interven (2019) (2)
Acute Aortic Arch Perforation During Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis and a Gothic Aortic Arch. (2017) (2)
Impact of Commissural Misalignment on Hydrodynamic Function Following Valve-in-Valve Intervention With the ACURATE neo. (2022) (2)
Redo-TAVR: What About the Coronary Arteries? (2020) (2)
P4190Incidence of infective endocarditis in patients considered at moderate risk (2018) (2)
Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type. (2022) (2)
Economical cost of percutaneous vascular closure with ProGlide™ and Prostar™ XL following transcatheter aortic valve replacement (2018) (2)
TAVR with the novel Navitor Titan™ transcatheter heart valve to treat aortic stenosis patients with large aortic annuli. (2022) (2)
Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry. (2023) (2)
Patient-Specific Computer Simulation of Transcatheter Aortic Valve Implantation in Bicuspid Aortic Valve Morphology (2019) (2)
Trials of Patent Foramen Ovale Closure. (2017) (2)
Sex Differences in Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2022) (2)
Is BASILICA the Standard for Preventing Coronary Obstruction in High-Risk Transcatheter Aortic Valve Replacement? (2021) (2)
Management of Myocardial Revascularization in Patients With Stable Coronary Artery Disease Undergoing Transcatheter Aortic Valve Implantation (2022) (2)
How to Define Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves: Facts and Misconceptions. (2020) (2)
Management and Outcome of Acute Ischemic Stroke Complicating Transcatheter Aortic Valve Replacement. (2022) (2)
Combined surgical and catheter‐based treatment of extensive thoracic aortic aneurysm and aortic valve stenosis (2015) (2)
Implications of hydrodynamic testing to guide sizing of self‐expanding transcatheter heart valves for valve‐in‐valve procedures (2019) (2)
CRT-700.41 Balloon-Expandable Valve for Treatment of Evolut Valve Failure: Implications on Neo-Skirt Height and Leaflet Overhang (2022) (1)
Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study. (2023) (1)
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity. (2022) (1)
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection. (2022) (1)
Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device. (2021) (1)
[Eisenmenger syndrome]. (2020) (1)
Expert Opinion Will PARTNER 2 Change My Practice? (2017) (1)
Aortic angle distribution and predictors of horizontal aorta in patients undergoing transcatheter aortic valve replacement. (2021) (1)
Impact of Echocardiographic Parameters on Recurrent Stroke in the Randomized REDUCE PFO Cryptogenic Stroke Trial (2021) (1)
Clinical outcomes of transcatheter aortic valve implantation in patients younger than 70 years rejected for surgery: the AMTRAC registry. (2021) (1)
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery. (2023) (1)
Valve thrombosis after transcatheter aortic valve replacement-cause for concern? (2020) (1)
30-Day Clinical Outcomes of a Self-Expanding Transcatheter Aortic Valve: The International PORTICO NG Study. (2023) (1)
The Potential Role of Transcatheter Heart Valve Interventions in Heart Failure Treatment. (2019) (1)
TCT-414 Patient-specific computer simulation to optimise transcatheter heart valve sizing and positioning in bicuspid aortic valve morphology (2018) (1)
Membranous septum morphology predicting the risk of conduction abnormalities after transcatheter aortic valve implantation. (2021) (1)
Unusual finding during screening for intracardiac thrombus in patients referred for percutaneous left atrial appendage closure. (2021) (1)
Transesophageal and intracardiac echocardiography to guide transcatheter tricuspid valve repair with the TriClip™ system (2021) (1)
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure. (2023) (1)
Mortality in adult patients with Eisenmenger Syndrome: 5-Years perspective (2021) (1)
Transcatheter Intervention for Coarctation of the Aorta: A Nordic Population-Based Registry With Long-Term Follow-Up. (2023) (1)
EFFECTS OF BOSENTAN ON PEAK OXYGEN CONSUMPTION, HEMODYNAMICS AND FUNCTIONAL CLASS IN FONTAN PATIENTS: A RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLIND STUDY (2014) (1)
[Percutaneous closure of the left atrial appendage for stroke prevention]. (2014) (1)
Transcatheter versus optimal medical treatment and surgical aortic valve replacement for aortic valve stenosis (2015) (1)
State‐of‐the‐art preclinical testing of the OMEGATM left atrial appendage occluder (2020) (1)
Tailoring the valve choice to the patient: contemporary choices and their optimal applications (2020) (1)
Percutaneous retrieval of an embolized left atrial appendage closure device from the left atrium in a patient with previous MitraClips (2019) (1)
Telescopic Catheter Technique for Difficult Aortic Valve Crossing During TAVR. (2020) (1)
Neo-Commissural Alignment During Transcatheter Aortic Valve Replacement: The LACRCO Algorithm. (2022) (1)
Sequential transcatheter aortic valve implantation due to valve dislodgement - a Portico valve implanted over a CoreValve bioprosthesis. (2017) (1)
Transcatheter pulmonary valve implantation: a melody to follow. (2019) (1)
Sealing Behavior in Transcatheter Bicuspid and Tricuspid Aortic Valves Replacement Through Patient-Specific Computational Modeling (2021) (1)
Treatment of late paravalvular regurgitation after transcatheter aortic valve implantation: prognostic implications. (2023) (1)
Impact of Computational Modeling on Transcatheter Left Atrial Appendage Closure Efficiency and Outcomes. (2023) (1)
ANP & BNP are potent markers for left ventricular dimensions, mass and function in patients with chronic heart failure (2000) (1)
Echocardiographic changes in right ventricular function after transcatheter versus surgical aortic valve replacement for severe aortic valve stenosis (2016) (1)
Does Subclinical Leaflet Thrombosis Impact the Durability of Bioprosthetic Aortic Valves? (2022) (1)
Durability of transcatheter bioprosthetic aortic valves. (2020) (1)
TCT-670 Optimal Transcatheter Heart Valve Sizing in Aortic Valve in Valve Implantation: Insights from the Valve in Valve International Data (VIVID) Registry. (2016) (1)
Characterization of Recurrent Strokes With and Without Patent Foramen Ovale Closure. (2018) (1)
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry. (2023) (1)
Hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) of aortic bioprostheses: An imaging finding or a complication? (2022) (1)
Pre-Procedural Imaging Modalities for Device Size Selection and Adaptive Nature of the Appendage in Patients Undergoing Percutaneous Left Atrial Appendage Closure (2018) (1)
Computational fluid dynamics after aortic coarctation repair (2002) (1)
Transcatheter mitral valve replacement or repair for secondary mitral regurgitation: a propensity score‐matched analysis (2023) (1)
Novel Neuroimaging Evidence of Brain Lesions Following Transcatheter Aortic Valve Replacement (2021) (1)
Initial experience with Edwards SAPIEN valve transcatheter implantation in native RVOT in Latvia. (2020) (1)
Incidence, Clinical Characteristics, and Impact of Absent Echocardiographic Signs in Patients with Infective Endocarditis after Transcatheter Aortic Valve Implantation. (2022) (1)
Patient-Tailored Aortic Valve Replacement (2021) (1)
Abstract 14270: Decline in Incidence of Sudden Cardiac Death Caused by Congenital Heart Disease After Implementation of Nationwide Prenatal Ultrasound Screening: A Nationwide Study (2016) (1)
Long-term follow-up of patients with Contained Annulus Ruptures after TAVI: the EuropeaN COntained RupturE ENCORE-registry. (2020) (1)
Procedural success in transaxillary transcatheter aortic valve implantation according to type of transcatheter heart valve: results from the multicenter TAXI registry. (2023) (0)
Cusp overlap technique during Valve-in-Valve TAVI using the novel Navitor transcatheter heart valve. (2021) (0)
338TRANSCATHETER MITRAL VALVE IMPLANTATION VIA TRANSAPICAL APPROACH: EARLY EXPERIENCE (2014) (0)
P3253Quantification of risk of infective endocarditis in patients considered at high risk by guidelines - A nationwide study (2017) (0)
[Transcatheter aortic valve implantation in Denmark]. (2018) (0)
Flow chart of the study population selection. (2014) (0)
Transcatheter Interventions for Atrioventricular Dysfunction in Patients with Adult Congenital Heart Disease: An International Case Series (2023) (0)
Difficult Cases and Complications from the Catheterization Laboratory: PFO Device Embolization and Settling in the Distal Aorta (2017) (0)
Abstract 102: Consistency of Efficacy of PFO Closure in the Gore Reduce Trial (2018) (0)
TCT-779 Quality of life after surgical and transcatheter aortic valve replacement in patients and their informal caregivers: real-world data contributing to establish value-based medicine in East Denmark (2018) (0)
TCT-549 Impact of COVID-19 Pandemic on TAVR Activity: A Worldwide Registry (2022) (0)
Temporal Trends in Survival Rates After Transcatheter Aortic Valve Replacement. (2022) (0)
TCT-82 Evaluation of Current Practices in Transcatheter Aortic Valve Replacement: The WRITTEN (WoRldwIde TAVR ExperieNce) Survey. (2016) (0)
Retinal Oxygenation in Patients With Systemic Hypoxia (2010) (0)
Remote education: what’s new? (2020) (0)
Computational simulation models to test bioprosthetic aortic valves: A valuable alternative or addition to bench testing? (2021) (0)
Percutaneous vs surgical axillary access for transcatheter aortic valve implantation: the TAXI registry. (2022) (0)
TCT-6 Incidence and Predictors of Hemodynamic Deterioration of Transcatheter and Surgical Bioprosthetic Aortic Valves: Pooled Analysis From the CoreValve Pivotal Trials (2019) (0)
TCT-80 Predictors of Residual Significant Mean Gradient After TAVR in Bicuspid Aortic Valve Stenosis: Insights From the BEAT International Collaborative Registry (2019) (0)
Late presentation of left atrial appendage erosion and perforation by an Amplatzer™ Amulet™ closure device: a case report (2020) (0)
Transcatheter interventions of coarctation of the aorta (CoA): a multinational population-based registry – procedural complications (2020) (0)
Transcatheter treatment of severe aortic stenosis in patients with complex coronary artery disease: case series and proposed therapeutic algorithm (2022) (0)
Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3. (2022) (0)
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation. (2020) (0)
Percutaneous Implantation of a Novel Interatrial Shunt Device in Patients with Heart Failure and Preserved or Mildly Reduced Ejection Fraction: Initial Results of a Pilot Trial (2014) (0)
Spontaneous thrombosis of a transcatheter aortic valve replacement‐induced aortic root pseudoaneurysm (2020) (0)
Percutaneous left atrial appendage closure in a surgically ligated left atrial appendage. (2021) (0)
The year in cardiology 2017: valvular heart disease (2018) (0)
The GORE® Septal Occluder (2015) (0)
Transcatheter aortic valve-in-valve implantation to treat aortic Para-valvular regurgitation after TAVI. (2022) (0)
TCT-39 Clinical Outcomes in SURTAVI Based on Revascularization Stratification (2017) (0)
TCT-727 Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis (2019) (0)
TCT CONNECT-86 Transcatheter Aortic Valve Replacement With the LOTUS Edge System: Early European Experience (2020) (0)
B-PO02-156 IMPACT OF LEFT ATRIAL APPENDAGE OCCLUSION WITH A LOBE AND DISC TYPE OCCLUDE DEVICE ON LEFT ATRIAL FUNCTION - THE LAFIT AMULET STUDY (2021) (0)
TCT-680 Pre-Procedural Work-up process In Patients Undergoing Transcatheter Aortic Valve Implantation: Results From The Written (WoRldwIde TAVI ExpieNce) Survey (2015) (0)
TCT-246 Hemodynamic Performance and Patient Prosthesis Mismatch in Small Aortic Annuli: A Comparison of Different Transcatheter Heart Valves (2021) (0)
Peripheral intravascular lithotripsy for transcatheter aortic valve implantation: a multicentre observational study (2022) (0)
37 – Aortic Regurgitation (2018) (0)
Transcatheter Implantation of Interatrial Shunt Devices to Lower Left Atrial Pressure in Heart Failure (2022) (0)
First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System (2023) (0)
Abstract 10589: Univentricular Hearts in Denmark 1977-2009: Decreasing Incidence, Improving Survival, and Several Predictors of Survival (2011) (0)
Commissural Alignment and Coronary Access after Transcatheter Aortic Valve Replacement (2023) (0)
INTERVENT IONS FOR VALVULAR D ISEASE AND HEART FA ILURE (2016) (0)
Percutaneous left atrial appendage closure for stroke prevention. (2014) (0)
Alternative Access Options for Transcatheter Aortic Valve Replacement. (2022) (0)
Pulmonary Vascular Disease in Patients with Fontan-Type Circulation (2017) (0)
Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: too early to draw conclusions. (2018) (0)
Striving for Perfection in Transcatheter LAA Closure: One Step Closer With Newer-Generation Devices. (2022) (0)
[Clinical aspects of Marfan syndrome]. (2011) (0)
Transcatheter aortic valve implantation in patients at low surgical risk. (2019) (0)
Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart). (2022) (0)
TCT-732 Transcatheter Aortic Valve Replacement is a Curative Treatment for Low-to-Intermediate Risk Patients with High Gradient Severe Aortic Valve Stenosis. (2016) (0)
Temporal Changes in the Surgical Management of Patients with Tetralogy of Fallot in Denmark - A Nationwide Cohort Study. (2023) (0)
Intracardiac Echocardiography: Procedural Steps and Clinical Application (2012) (0)
TCTAP A-036 Local Experience: Transcatheter Aortic Valve Replacement on Bicuspid Aortic Valve with Lotus Valve System (2016) (0)
Abstract 2347: Pulmonary Regurgitation: The Impact on Right Ventricle and the Effect of Percutaneous Pulmonary Valve Replacement (2007) (0)
[Percutaneous mitral plasty in Denmark]. (2011) (0)
Will the Evolut Low Risk trial change my practice? (2019) (0)
TCT-24 Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Device During TAVR: Results From the Multicenter TASK (Transcatheter Aortic valve implantation in-hoSpital stroKe) Study (2019) (0)
Step-by-Step Device Closure of Persistent Foramen Ovale (PFO) (2021) (0)
[Cerebral embolic protection during transcatheter aortic valve replacement: analysis of data from PROTECTED-TAVR and future perspectives]. (2022) (0)
Simplification of Transcatheter Aortic Valve Replacement. (2019) (0)
The EuroIntervention health check 2019. (2019) (0)
Time to expand indications for thoracic endovascular aortic repair (TEVAR) in the setting of aortic dissection? (2019) (0)
The Influence of Indication on Intermediate-term Survival after Full Root Freestyle Implantation: A Multicenter Study (2020) (0)
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis. (2022) (0)
Temporal Trends and Contemporary Outcomes After Transcatheter Aortic Valve Replacement With Evolut PRO/PRO+ Self-Expanding Valves: Insights From the NEOPRO/NEOPRO-2 Registries (2023) (0)
[Transcatheter aortic valve implantation in patients with severe aortic stenosis]. (2012) (0)
Reply (2019) (0)
Vascular function in adults with cyanotic congenital heart disease (2020) (0)
The efficacy and safety of macitentan in Fontan-palliated patients: results of the 52-week randomised, placebo-controlled RUBATO trial (2022) (0)
Strengths and weaknesses of different types of TAVI study. (2020) (0)
TCT-638 Rhythm Changes And Pacemaker Incidence Associated With a Repositionable Self Expanding TAVI System: A Prospective Multicenter Analysis (2015) (0)
P6382Atrial fibrillation after closure of persistent foramen ovale in the REDUCE clinical trial (2018) (0)
Univentricular Heart - Management and Prognosis CONGENITAL (2010) (0)
Discussing Lifetime Management of Patients With Severe Aortic Valve Stenosis Should Be Standard at Heart Team Meetings. (2022) (0)
TCT-533 Long-Term Multimodality Imaging and Histological Assessments of a Novel Transcatheter Tricuspid Valve Replacement in Large Animal Model (2022) (0)
[Transcatheter aortic valve implantation in Denmark]. (2018) (0)
Major stroke in a 19-year-old patient with a univentricular heart (2013) (0)
Facilitation techniques to cross the interatrial septum with intracardiac echocardiography during left atrial appendage closure (2022) (0)
Long-Term Durability of the Next-Generation Acurate neo 2 Transcatheter Heart Valve: Insights From Bench Testing to 25 Years. (2021) (0)
Improved cardiac output and stroke volume response in Senning versus Mustard (2001) (0)
Three-Year Outcomes of Transcatheter Aortic Valve Replacement (2023) (0)
TCT-684 Approach and Procedural Management in Patients Undergoing Transcatheter Aortic Valve Implantation: Results From The Written (WoRldwIde TAVI ExperieNce) Survey (2015) (0)
What is the future role of cerebral embolic protection in transcatheter aortic valve implantation? (2022) (0)
Long‐Term Cardiovascular Health After Pregnancy in Danish Women With Congenital Heart Disease. A Register‐Based Cohort Study Between 1993 and 2016 (2022) (0)
1212Long-term risk of infective endocarditis following transcatheter aortic valve implantation: a nationwide cohort study (2018) (0)
THE ALIGNMENT OF TRANSCATHETER AORTIC VALVE NEO-COMMISSURES (ALIGN TAVR) STUDY (2020) (0)
Transkateteraortaklapimplantation i Danmark (2018) (0)
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicenter, observational, post-market surveillance study. (2022) (0)
ADOLESCENTS AND ADULTS WITH FONTAN CIRCULATION: BASELINE CHARACTERISTICS FROM THE PREPARE FONTAN REGISTRY (2018) (0)
[Transcatheter replacement of the aortic valve--a novel treatment modality for high-risk patients]. (2009) (0)
TCT-235 Annular Size and Its Interaction With Self-Expandable Versus Balloon-Expandable Transcatheter Heart Valves for the Treatment of Patients With Severe Bicuspid Aortic Valve Stenosis: Insights from the BEAT Registry (2021) (0)
Prophylactic Permanent Pacemaker Implantation in Patients With Right Bundle Branch Block Undergoing TAVR. (2021) (0)
93The high burden of rehospitalisations following transcatheter aortic valve implantation (2019) (0)
PP.22.21: ONE YEAR CLINICAL OUTCOME OF TRANSCATHETER TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION USING INTERATRIAL IMPLANT TO LOWER LEFT ATRIAL PRESSURE (2015) (0)
Abstract WMP110: Presence, Volume, and Location of New Ischemic Injury on MRI in Stroke Patients Who Undergo PFO Closure Compared to Patients Treated Medically: An Analysis of the REDUCE Trial (2020) (0)
Calcium-Induced Infolding of a Self-Expanding Transcatheter Aortic Valve in Type 1 Bicuspid Aortic Valve Stenosis. (2022) (0)
Management of right heart lesions in pregnancy (2016) (0)
TCT-657 Post-Procedural And Follow-Up Management In Patients Undergoing Transcatheter Aortic Valve Implantation: Results From The Written (WoRldwIde TAVI ExpieNce) Survey (2015) (0)
Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation (2017) (0)
Transcatheter aortic valve implantation with the LOTUS Edge system: early European experience (2020) (0)
Transcatheter intervention of coarctation of the aorta (CoA): a multinational population-based registry – effect on hypertension (2020) (0)
The association of prior carpal tunnel syndrome surgery with adverse cardiovascular outcomes and long-term mortality after aortic valve replacement (2021) (0)
ONE YEAR RESULTS OF A NOVEL INTERATRIAL SHUNT THERAPY FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION (2015) (0)
Catheter-based intervention for symptomatic patient with severe mitral regurgitation and very poor left ventricular systolic function - Safe but no room for complacency. (2015) (0)
Grow your own valve. (2017) (0)
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification? (2022) (0)
94Course of contained annulus ruptures after TAVI: the ENCORE (European contained rupture)-registry (2019) (0)
Corrigendum to 'Comparison of Antiplatelet Therapies for Prevention of Patent Foramen Ovale-Associated Stroke' [Journal of Stroke and Cerebrovascular Diseases, Vol. 29, No. 4 (April), 2020: 104632]. (2020) (0)
Population-based study of long-term outcome of mustard/senning correction for transposition of the great arteries (TGA) (2014) (0)
Surgical feasibility of ascending aorta manipulation after transcatheter aortic valve implantation: a computed tomography theoretical analysis (0)
Reply: 1-Year Results From the NOTION Randomized Clinical Trial: Weighing Complications Against Functional Outcomes. (2015) (0)
How should I treat an iatrogenic type IIA DeBakey-Stanford aortic dissection during a percutaneous right coronary artery intervention? (2017) (0)
2-Year Outcomes after Transcatheter Mitral Valve Replacement: Results from the CHOICE-MI Registry (2023) (0)
Impact of implantation technique on conduction disturbances for TAVR with the self‐expanding portico/navitor valve (2022) (0)
Management of Fontan Patients (2017) (0)
Recent Developments and Current Status of Transcatheter Aortic Valve Replacement Practice in Latin America - the WRITTEN LATAM Study. (2022) (0)
85Patient-specific computer simulation to elucidate the role of contact pressure in the development of new conduction abnormalities after catheter based implantation of a self-expanding aortic valve (2017) (0)
Long-term changes in coronary physiology after aortic valve replacement. (2022) (0)
[Molecular biological aspects of Marfan syndromes]. (2011) (0)
Response by Kempny et al to Letter Regarding Article, "Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study". (2017) (0)
Reply: Exploring the Role of Transcatheter Aortic Valve Replacement as the Preferred Treatment for Lower-Risk Patients. (2015) (0)
680 Peripheral intravascular lithotripsy of ILEO-femoral arteries to facilitate transfemoral TAVI: a multicentric prospective registry (2021) (0)
HEMODYNAMIC CAUSES FOR EXERCISE INTOLERANCE IN FONTAN PATIENTS (2014) (0)
Transcatheter mitral valve repair: a step back from the edge. (2018) (0)
Outcomes of the roll-in cohort of the Amulet IDE trial of left atrial appendage occlusion (2022) (0)
Syddansk Universitet Short- and Long-Term Mortality and Stroke Risk After Transcatheter Aortic Valve Implantation (2017) (0)
Intravascular assessment of coronary arteries in patients with cyanotic congenital heart disease. (2019) (0)
Comparison of Antiplatelet Therapies for Prevention of Patent Foramen Ovale-Associated Stroke. (2020) (0)
TAVR for All? The Surgical Perspective (2022) (0)
Reply: Choosing the Right Valve. (2019) (0)
Slender Sheaths Have the Potential to Expand the (0)
SYMPOSIUM: The 99th Berzelius symposium: The cardiac patient from birth to adulthood (2020) (0)
TCT-97 Preserving coronary access after Valve-in-TAVI: a glimpse into the future. (2018) (0)
P5240Transthoracic echocardiography may rule-out leaflet dysfunction after transcatheter aortic valve replacement, a novel algorithm based on leaflet morphology and color doppler flow characteristics (2017) (0)
Neurohormones in the prediction of anti‐remodelling effects on the left ventricle during β‐blockade with metoprolol in chronic heart failure (2000) (0)
Intra-cardiac echocardiography in diagnosis of subvalvular right-sided atrioventricular valve stenosis. (2022) (0)
Pulmonary endothelial dysfunction does not contribute to pulmonary regurgitation late after tetralogy of Fallot repair (2001) (0)
Comparison of Predicted and Confirmed Neo-Left Ventricular Outflow Tract After Transcatheter Mitral Valve Replacement. (2022) (0)
Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves: the TRANSIT-PPM international project (2022) (0)
The Strengths and Weaknesses of the LAA Covering Disc Occluders-Conceptually and in Practice. (2023) (0)
Multimodality Imaging to Assess Leaflet Height in Mitral Bioprosthetic Valves: Implications for Mitral Valve-in-Valve Procedure. (2022) (0)
TCT-690 Initial Deployment Orientation of ACURATE-neo THV and Final Commissural Alignment: A Pilot Study on Optimizing Post-Procedural Coronary Access (2019) (0)
Percutaneous Recanalization of Interrupted Aortic Arch Using Laser Atherectomy (2023) (0)
Coarctation (2018) (0)
[Percutaneous stented pulmonary valve implantation]. (2010) (0)
The Strengths and Weaknesses of the LAA Covering Disc Occluders-Conceptually and in Practice. (2022) (0)
Transcatheter Aortic Valve Implantation With and Without Resheathing and Repositioning: A Systematic Review and Meta‐analysis (2022) (0)
Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR: Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study (2022) (0)
Investigation of retinal function in chronic systemic hypoxia secondary to cardiac disease in human (2015) (0)
P926Comparative safety and effectiveness of vitamin K antagonist and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve implantation (2019) (0)
Correction to: Predictors of high residual gradient after transcatheter aortic valve replacement in bicuspid aortic valve stenosis (2021) (0)
Beneficial effects on left ventricular dimensions and function during β‐blockade with metoprolol in the treatment of chronic heart failure (2000) (0)
Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve‐in‐valve procedure for a failed surgical bioprosthetic aortic valve (2023) (0)
TCT-742 Percutaneous left atrial appendage closure following transcatheter aortic valve replacement: results from the ATTRACTIVE study (2018) (0)
TCT-498 Outcomes of Transcatheter Aortic Valve implantation With Evolut PRO/PRO+ or SAPIEN 3 Ultra devices: The International, Multicenter OPERA-TAVI Registry (2022) (0)
Will PARTNER 2 Change My Practice (2016) (0)
TCT-271 Outcomes of Transcatheter Aortic Valve Replacement Using Balloon vs Self-Expandable Valves Stratified by Center Valve Preference – Insights From the Multicenter Aortic+Mitral TRAnsCatheter (AMTRAC) Registry (2021) (0)
Re-hospitalisation after transcatheter aortic valve implantation: the HOSPITAVI study (2022) (0)
Redo Transcatheter Aortic Valve Implantation with the ALLEGRA Transcatheter Heart Valve: Insights from Bench Testing. (2022) (0)
EuroIntervention and EuroPCR 2019 - together embodying the spirit of interventional cardiology. (2019) (0)
[Platypnoea-orthodeoxia: a rare cause of severe dyspnoea]. (2013) (0)
TCT-458 Transcatheter Aortic Valve Replacement in Patients With Extra-Small Aortic Annulus (2022) (0)
Patent Foramen Ovale Closure Decreases the Incidence but Not the Size of New Brain Infarction on Magnetic Resonance Imaging (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Lars Søndergaard?

Lars Søndergaard is affiliated with the following schools:

Ghent University
Capital Medical University
Aalborg University
Lund University
University of Copenhagen
Columbia University